| Rosario J Ligresti, MD | |
|
20 Prospect Ave Ste 615, Hackensack, NJ 07601-1997 | |
| (515) 996-3091 | |
| (551) 996-5727 |
| Full Name | Rosario J Ligresti |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 32 Years |
| Location | 20 Prospect Ave Ste 615, Hackensack, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235135229 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | 7877600 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hackensack University Medical Center | Hackensack, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hackensack Meridian Health Medical Group - Specialty Care Pc | 9133032519 | 1090 |
News Archive
Catamaran Corporation, a leading provider of pharmacy benefit management (PBM) services and technology solutions, announced today the completion, effective as of April 8, 2015, of its previously disclosed acquisition of Healthcare Solutions, for a purchase price of $405 million in cash, subject to certain customary post-closing adjustments. The purchase price was funded from Catamaran's existing cash balance.
Genzyme Corporation (Nasdaq: GENZ) announced today that the FDA's Oncologic Drugs Advisory Committee voted 9 to 3 that a randomized, controlled trial is needed to support the currently proposed label expansion for Clolar® (clofarabine) in adult myeloid leukemia (AML). The committee found that the single-arm clinical study results submitted to support the label expansion showed Clolar was an active agent in acute AML patients, but concluded that a randomized clinical trial should be necessary to better interpret Clolar's efficacy and safety in the proposed patient population.
A blood test used to measure patterns of ribonucleic acid (RNA) expression can help determine if fever in infants under 2 months old is caused by bacterial or viral infection, according to a preliminary study recently published in the Journal of the American Medical Association.
Researchers at the University of Minnesota have created a new lab-grown blood vessel replacement that is composed completely of biological materials, but surprisingly doesn't contain any living cells at implantation. The vessel, that could be used as an "off the shelf" graft for kidney dialysis patients, performed well in a recent study with nonhuman primates.
New cancer drugs allow doctors to tailor treatment based on the genetic profile of a patient's tumor. However, these drugs don't work at all in some patients, and they lose their effectiveness in others.
› Verified 8 days ago
| Entity Name | Hackensack Meridian Health Medical Group - Specialty Care Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215989249 PECOS PAC ID: 9133032519 Enrollment ID: O20031111000524 |
News Archive
Catamaran Corporation, a leading provider of pharmacy benefit management (PBM) services and technology solutions, announced today the completion, effective as of April 8, 2015, of its previously disclosed acquisition of Healthcare Solutions, for a purchase price of $405 million in cash, subject to certain customary post-closing adjustments. The purchase price was funded from Catamaran's existing cash balance.
Genzyme Corporation (Nasdaq: GENZ) announced today that the FDA's Oncologic Drugs Advisory Committee voted 9 to 3 that a randomized, controlled trial is needed to support the currently proposed label expansion for Clolar® (clofarabine) in adult myeloid leukemia (AML). The committee found that the single-arm clinical study results submitted to support the label expansion showed Clolar was an active agent in acute AML patients, but concluded that a randomized clinical trial should be necessary to better interpret Clolar's efficacy and safety in the proposed patient population.
A blood test used to measure patterns of ribonucleic acid (RNA) expression can help determine if fever in infants under 2 months old is caused by bacterial or viral infection, according to a preliminary study recently published in the Journal of the American Medical Association.
Researchers at the University of Minnesota have created a new lab-grown blood vessel replacement that is composed completely of biological materials, but surprisingly doesn't contain any living cells at implantation. The vessel, that could be used as an "off the shelf" graft for kidney dialysis patients, performed well in a recent study with nonhuman primates.
New cancer drugs allow doctors to tailor treatment based on the genetic profile of a patient's tumor. However, these drugs don't work at all in some patients, and they lose their effectiveness in others.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rosario J Ligresti, MD 20 Prospect Ave Ste 615, Hackensack, NJ 07601-1997 Ph: (515) 996-3091 | Rosario J Ligresti, MD 20 Prospect Ave Ste 615, Hackensack, NJ 07601-1997 Ph: (515) 996-3091 |
News Archive
Catamaran Corporation, a leading provider of pharmacy benefit management (PBM) services and technology solutions, announced today the completion, effective as of April 8, 2015, of its previously disclosed acquisition of Healthcare Solutions, for a purchase price of $405 million in cash, subject to certain customary post-closing adjustments. The purchase price was funded from Catamaran's existing cash balance.
Genzyme Corporation (Nasdaq: GENZ) announced today that the FDA's Oncologic Drugs Advisory Committee voted 9 to 3 that a randomized, controlled trial is needed to support the currently proposed label expansion for Clolar® (clofarabine) in adult myeloid leukemia (AML). The committee found that the single-arm clinical study results submitted to support the label expansion showed Clolar was an active agent in acute AML patients, but concluded that a randomized clinical trial should be necessary to better interpret Clolar's efficacy and safety in the proposed patient population.
A blood test used to measure patterns of ribonucleic acid (RNA) expression can help determine if fever in infants under 2 months old is caused by bacterial or viral infection, according to a preliminary study recently published in the Journal of the American Medical Association.
Researchers at the University of Minnesota have created a new lab-grown blood vessel replacement that is composed completely of biological materials, but surprisingly doesn't contain any living cells at implantation. The vessel, that could be used as an "off the shelf" graft for kidney dialysis patients, performed well in a recent study with nonhuman primates.
New cancer drugs allow doctors to tailor treatment based on the genetic profile of a patient's tumor. However, these drugs don't work at all in some patients, and they lose their effectiveness in others.
› Verified 8 days ago
Dr. Sean Shabbir Sadikot, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 20 Prospect Ave Ste 707, Hackensack, NJ 07601 Phone: 551-996-2211 Fax: 551-996-5727 | |
Mr. Angel J Mulkay, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 493 Essex Avenue, Hackensack, NJ 07601 Phone: 201-996-9244 Fax: 201-601-0995 | |
Dr. Morris Samuel Friedman, DO Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 52 1st St, Hackensack, NJ 07601 Phone: 201-342-0066 Fax: 201-342-0079 | |
Dr. David Serur, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 20 Prospect Ave Ste 406, Hackensack, NJ 07601 Phone: 551-996-2608 Fax: 551-996-0826 | |
Jerome F Levine, M.D. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 20 Prospect Ave, Suite 507, Hackensack, NJ 07601 Phone: 201-487-4088 | |
Dr. Noa Biran, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 92 2nd St, Hackensack, NJ 07601 Phone: 551-996-8704 Fax: 551-996-0582 | |
Naresh Chanderi, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 344 Prospect Ave, Hackensack, NJ 07601 Phone: 201-342-4233 Fax: 201-342-4840 |